SlideShare a Scribd company logo
Cross-sectional studies
 Cross-sectional study is also called prevalence study.
 Cross-sectional study is the simplest form of
observational study.
 It is based on single examination of cross-section of
population at one point of time.
 If the sampling methodology is accurate, results can
be projected to the entire population.
 They are more useful for chronic illnesses, e.g.
hypertension.
 Cross-sectional studies save on time and resources,
but provide very little information about natural
history of disease and incidence of illness.
Case- control studies
 It start from effect and then proceed to cause
 Both exposure and outcome have occurred
before start of the study
 The study proceeds backwards from effect to
cause
 Select subjects based on their disease status.
A group of individuals that are disease positive
(the "case" group) is compared with a group of
disease negative individuals (the "control"
group).
 The control group should ideally come from the
same population that gave rise to the cases.
Basic steps in a case-control study
 1. Selection of cases and controls
 2. Matching
 3. Measurement of exposure
 4. Analysis and interpretation.
 A 2×2 table is constructed, displaying exposed cases
(A), exposed controls (B), unexposed cases (C) and
unexposed controls (D).
 To measure association is the odds ratio (OR), which
is the ratio of the odds of exposure in the cases (A/C)
to the odds of exposure in the controls (B/D), i.e.
OR = (AD/BC).
CASE CONTROLS
EXPOSED A B
UNEXPOSED C D
Case with lung
cancer
Control without
lung cancer
Smokers (less
than 5 )
33 (a) 55 (b)
Non-Smokers
(less than 5 )
2 (c) 27 (d)
The first step is to find out
1. Exposure rates among cases
=a/(ac) = 33/35 =94.2%
2. Exposure rate among the controls
=b/(bd) = 55/82 =67%
 If the exposure rate among the cases is
more than the controls.
 We must see if the exposure rate among the
cases is significantly more than the controls.
This is done by using the chi-square test
 It is significant if p is less than 0.05.
Odds ratio
 It is a measure of strength of association between the
risk factor and outcome.
 The derivation of the odds ratio is based on three
assumptions:
● The disease being investigated is relatively rare
● The cases must be representative of those with the
disease
● The controls must be representative of those without the
disease.
Odds ratio a.d/b.c
33X27/55X2 = 8.1
 People who smoke less than 5 cigarettes per
day showed a risk of having lung cancer 8.1
times higher as compared to non-smokers.
 OR is > 1- "those with the disease are more
likely to have been exposed,"
OR close to 1 then the exposure and disease
are not likely associated.
OR <1-exposure is a protective factor in the
causation of the disease.
 Case control studies are usually faster and more
cost effective
 Sensitive to bias (selection bias).
 The main challenge is to identify the appropriate
control group;
 The distribution of exposure among the control
group should be representative of the distribution
in the population that gave rise to the cases.
Cohort Study
 It look at cause and proceed to effect
 study before the disease is manifest and proceed
to study over a period of time for the disease to
occur.
 Cohort means a group of people sharing a
common experience.
 Cohort studies are often prospective studies, they
can be retrospective also, or a combination of
both prospective and retrospective components
can be brought in.
 Steps in a cohort study:
1. Selection of study subjects
2. Obtaining data on exposur
3. Selection of comparison groups
4. Follow-up
5. Analysis.
CHD Develop CHD does not
develop
total
Smoker 84 (a) 2916 (b) 3000 (a+b)
Nno-smoker 87 (C) 4913 (d) 5000 (c+d)
Total 171 (a+c) 7829 (b+d) 8000
The incidence rates of CHD among smokers i.e. a/(a+b)
=84/3000 =28 per 1000
The incidence rates of CHD among non-smokers i.e.
=c/(c+d)
=87/5000 =17.4 per 1000
 Then, we must determine if the
incidence rate among the smokers is
significantly more than among the
non-smokers by using the chi-square
test.
Relative risk (RR)
 It is ratio of incidence of the disease among the exposed and
incidence among the non-exposed.
RR (incidence of disease among exposed)/
(Incidence of disease among non-exposed)
=a/(ab)/c/(cd)
=28/17.4
=1.6
 If RR is more than 1, then there is a positive association
 If RR is equal to 1, then there is no association
 Smokers develop CHD 1.6 times more than nonsmokers.
Attributable risk (AR)
 This is defined as amount or proportion of disease
incidence that can be attributed to a specific exposure.
 It indicates to what extent the disease under study can be
attributed to the exposure:
(incidence of disease among exposed)
- (incidence of disease among non exposed)/
(Incidence of disease among exposed)
=28-17.4/28
= 10.6/28 = 0.379 = 37.9%
 37. 9% of CHD among the smokers was due to smoking.
Differences between case-control and
cohort studies
Case-control Cohort studies
Proceeds from effect to Proceeds from cause to
●
cause effect
Starts with the disease Starts with people
●
exposed to risk factor
Rate of exposure among Tests frequency of disease
●
exposed and those not among those exposed
and exposed is studied those not exposed
First approach to testing Reserved for testing
●
hypothesis precisely define
hypothesis
 Involves small number of Involves large number of
●
subjects subjects
 Less time and resources More time and cost
●
intensive
 Suitable for rare diseases Difficult to conduct for
●
rare
diseases
 Yields odds ratio Yields incidence rates,
●
RR, AR and population
atributable risk
 Cannot yield information Information about more
●
about diseases one other than disease is possible
than selected for
Randomized Control Studies
 Essential elements are:
 Drawing up a strict protocol,
 selecting reference and
 experimental populations,
 randomization,
 intervention,
 follow-up
 assessment of outcome.
 Randomization is a statistical procedure where
participants are allocated into groups called study
and control groups to receive or not to receive an
experimental therapeutic or preventive
procedure, intervention.
Randomization is an attempt to avoid bias and allow
comparability.
 Study designs include
Concurrent parallel
Crossover type of study designs.
 In the former, study and control
groups will be studied parallel
whereas in the latter all the
participants will have the benefit of
treatment after a particular period
because the control group becomes
study group.
Types of randomized control studies
are:
Clinical trials, e.g. drug trials
Preventive trials, e.g. trials of vaccines
Risk factor trials, e.g. trials of risk factors of
cardiovascular disease, e.g. tobacco use, physical
activity, diet, etc.
Cessation experiments, e.g. smoking cessation
experiments for studying lung cancer.
What is bias?
 Bias is systematic error that comes in.
 Bias on the part of participants if they know
they belong to study group—participant bias
 bias because of observer if he knows that he
is dealing with study group—observer bias
 bias because of investigator investigator bias,
if he knows he is dealing with study group.
In order to prevent this, a technique called
blinding is adopted.
Concept of blinding
 Single blind trial means participant will not
know whether he belongs to study group
or control group.
 In double blind studies, both the
participant and the observer will not be
aware.
 In triple blind study, the participant,
observer as well as the investigator will not
be aware

More Related Content

PPTX
.Analytical epidemiology.pptx
PPTX
study design (post)المحاضرة دي من أهم المحاضرات اللي بييجي منها في الامتحان.pptx
PPTX
Case-control study un.uob.pptx
PPTX
Study design used in pharmacoepidemiology
PPTX
Cohort Study Design- Research Methodology
PPTX
Case control study
PPTX
Analytical epidemiology
PPTX
COHORT STUDY.pptx...........................
.Analytical epidemiology.pptx
study design (post)المحاضرة دي من أهم المحاضرات اللي بييجي منها في الامتحان.pptx
Case-control study un.uob.pptx
Study design used in pharmacoepidemiology
Cohort Study Design- Research Methodology
Case control study
Analytical epidemiology
COHORT STUDY.pptx...........................

Similar to epidemiology with part 1(complete) 2.ppt (20)

PPTX
Statistics and biostatistics
PDF
analyticalstudydesignscasecontrolstudy-160305174642.pdf
PPTX
Analytical study designs case control study
PPTX
Case control study
PPTX
Case control studies
PPTX
Session 1-Introduction to operational research.pptx
PPTX
Role of epidemiology &amp; statistics in
PPTX
EPIDEMIOLOGICAL METHODS -MOLECULAR, SEROLOGICAL
PPT
Clinical trial design
PPTX
Case control & cohort study
PPTX
ANALYTICAL STUDIES.pptx
PPTX
Analytical study designs.pptx
PPTX
Quantitative Methods.pptx
PDF
“Cohort Study Design and Results: A Comprehensive Overview”
PPTX
Case control study
PPT
Epidemiological Designs.ppt
PPTX
Cohort Study.pptx
PPTX
Public Health-Experimental Epidemiology.pptx
PPTX
5. cohort studies
PDF
Research studies and classification of research studies
Statistics and biostatistics
analyticalstudydesignscasecontrolstudy-160305174642.pdf
Analytical study designs case control study
Case control study
Case control studies
Session 1-Introduction to operational research.pptx
Role of epidemiology &amp; statistics in
EPIDEMIOLOGICAL METHODS -MOLECULAR, SEROLOGICAL
Clinical trial design
Case control & cohort study
ANALYTICAL STUDIES.pptx
Analytical study designs.pptx
Quantitative Methods.pptx
“Cohort Study Design and Results: A Comprehensive Overview”
Case control study
Epidemiological Designs.ppt
Cohort Study.pptx
Public Health-Experimental Epidemiology.pptx
5. cohort studies
Research studies and classification of research studies
Ad

Recently uploaded (20)

PPTX
Infosys Presentation by1.Riyan Bagwan 2.Samadhan Naiknavare 3.Gaurav Shinde 4...
PPT
Project quality management in manufacturing
PPTX
bas. eng. economics group 4 presentation 1.pptx
PDF
R24 SURVEYING LAB MANUAL for civil enggi
PDF
PPT on Performance Review to get promotions
PPTX
M Tech Sem 1 Civil Engineering Environmental Sciences.pptx
PDF
The CXO Playbook 2025 – Future-Ready Strategies for C-Suite Leaders Cerebrai...
PPTX
Sustainable Sites - Green Building Construction
PPTX
MCN 401 KTU-2019-PPE KITS-MODULE 2.pptx
PPT
CRASH COURSE IN ALTERNATIVE PLUMBING CLASS
PDF
PRIZ Academy - 9 Windows Thinking Where to Invest Today to Win Tomorrow.pdf
PPTX
Recipes for Real Time Voice AI WebRTC, SLMs and Open Source Software.pptx
PPTX
CARTOGRAPHY AND GEOINFORMATION VISUALIZATION chapter1 NPTE (2).pptx
PDF
Operating System & Kernel Study Guide-1 - converted.pdf
PPTX
MET 305 2019 SCHEME MODULE 2 COMPLETE.pptx
PPTX
web development for engineering and engineering
PDF
Enhancing Cyber Defense Against Zero-Day Attacks using Ensemble Neural Networks
PPTX
FINAL REVIEW FOR COPD DIANOSIS FOR PULMONARY DISEASE.pptx
PPTX
additive manufacturing of ss316l using mig welding
PPTX
OOP with Java - Java Introduction (Basics)
Infosys Presentation by1.Riyan Bagwan 2.Samadhan Naiknavare 3.Gaurav Shinde 4...
Project quality management in manufacturing
bas. eng. economics group 4 presentation 1.pptx
R24 SURVEYING LAB MANUAL for civil enggi
PPT on Performance Review to get promotions
M Tech Sem 1 Civil Engineering Environmental Sciences.pptx
The CXO Playbook 2025 – Future-Ready Strategies for C-Suite Leaders Cerebrai...
Sustainable Sites - Green Building Construction
MCN 401 KTU-2019-PPE KITS-MODULE 2.pptx
CRASH COURSE IN ALTERNATIVE PLUMBING CLASS
PRIZ Academy - 9 Windows Thinking Where to Invest Today to Win Tomorrow.pdf
Recipes for Real Time Voice AI WebRTC, SLMs and Open Source Software.pptx
CARTOGRAPHY AND GEOINFORMATION VISUALIZATION chapter1 NPTE (2).pptx
Operating System & Kernel Study Guide-1 - converted.pdf
MET 305 2019 SCHEME MODULE 2 COMPLETE.pptx
web development for engineering and engineering
Enhancing Cyber Defense Against Zero-Day Attacks using Ensemble Neural Networks
FINAL REVIEW FOR COPD DIANOSIS FOR PULMONARY DISEASE.pptx
additive manufacturing of ss316l using mig welding
OOP with Java - Java Introduction (Basics)
Ad

epidemiology with part 1(complete) 2.ppt

  • 1. Cross-sectional studies  Cross-sectional study is also called prevalence study.  Cross-sectional study is the simplest form of observational study.  It is based on single examination of cross-section of population at one point of time.  If the sampling methodology is accurate, results can be projected to the entire population.  They are more useful for chronic illnesses, e.g. hypertension.  Cross-sectional studies save on time and resources, but provide very little information about natural history of disease and incidence of illness.
  • 2. Case- control studies  It start from effect and then proceed to cause  Both exposure and outcome have occurred before start of the study  The study proceeds backwards from effect to cause
  • 3.  Select subjects based on their disease status. A group of individuals that are disease positive (the "case" group) is compared with a group of disease negative individuals (the "control" group).  The control group should ideally come from the same population that gave rise to the cases.
  • 4. Basic steps in a case-control study  1. Selection of cases and controls  2. Matching  3. Measurement of exposure  4. Analysis and interpretation.
  • 5.  A 2×2 table is constructed, displaying exposed cases (A), exposed controls (B), unexposed cases (C) and unexposed controls (D).  To measure association is the odds ratio (OR), which is the ratio of the odds of exposure in the cases (A/C) to the odds of exposure in the controls (B/D), i.e. OR = (AD/BC). CASE CONTROLS EXPOSED A B UNEXPOSED C D
  • 6. Case with lung cancer Control without lung cancer Smokers (less than 5 ) 33 (a) 55 (b) Non-Smokers (less than 5 ) 2 (c) 27 (d) The first step is to find out 1. Exposure rates among cases =a/(ac) = 33/35 =94.2% 2. Exposure rate among the controls =b/(bd) = 55/82 =67%
  • 7.  If the exposure rate among the cases is more than the controls.  We must see if the exposure rate among the cases is significantly more than the controls. This is done by using the chi-square test  It is significant if p is less than 0.05.
  • 8. Odds ratio  It is a measure of strength of association between the risk factor and outcome.  The derivation of the odds ratio is based on three assumptions: ● The disease being investigated is relatively rare ● The cases must be representative of those with the disease ● The controls must be representative of those without the disease.
  • 9. Odds ratio a.d/b.c 33X27/55X2 = 8.1  People who smoke less than 5 cigarettes per day showed a risk of having lung cancer 8.1 times higher as compared to non-smokers.
  • 10.  OR is > 1- "those with the disease are more likely to have been exposed," OR close to 1 then the exposure and disease are not likely associated. OR <1-exposure is a protective factor in the causation of the disease.
  • 11.  Case control studies are usually faster and more cost effective  Sensitive to bias (selection bias).  The main challenge is to identify the appropriate control group;  The distribution of exposure among the control group should be representative of the distribution in the population that gave rise to the cases.
  • 12. Cohort Study  It look at cause and proceed to effect  study before the disease is manifest and proceed to study over a period of time for the disease to occur.  Cohort means a group of people sharing a common experience.  Cohort studies are often prospective studies, they can be retrospective also, or a combination of both prospective and retrospective components can be brought in.
  • 13.  Steps in a cohort study: 1. Selection of study subjects 2. Obtaining data on exposur 3. Selection of comparison groups 4. Follow-up 5. Analysis.
  • 14. CHD Develop CHD does not develop total Smoker 84 (a) 2916 (b) 3000 (a+b) Nno-smoker 87 (C) 4913 (d) 5000 (c+d) Total 171 (a+c) 7829 (b+d) 8000 The incidence rates of CHD among smokers i.e. a/(a+b) =84/3000 =28 per 1000 The incidence rates of CHD among non-smokers i.e. =c/(c+d) =87/5000 =17.4 per 1000
  • 15.  Then, we must determine if the incidence rate among the smokers is significantly more than among the non-smokers by using the chi-square test.
  • 16. Relative risk (RR)  It is ratio of incidence of the disease among the exposed and incidence among the non-exposed. RR (incidence of disease among exposed)/ (Incidence of disease among non-exposed) =a/(ab)/c/(cd) =28/17.4 =1.6  If RR is more than 1, then there is a positive association  If RR is equal to 1, then there is no association  Smokers develop CHD 1.6 times more than nonsmokers.
  • 17. Attributable risk (AR)  This is defined as amount or proportion of disease incidence that can be attributed to a specific exposure.  It indicates to what extent the disease under study can be attributed to the exposure: (incidence of disease among exposed) - (incidence of disease among non exposed)/ (Incidence of disease among exposed) =28-17.4/28 = 10.6/28 = 0.379 = 37.9%  37. 9% of CHD among the smokers was due to smoking.
  • 18. Differences between case-control and cohort studies Case-control Cohort studies Proceeds from effect to Proceeds from cause to ● cause effect Starts with the disease Starts with people ● exposed to risk factor Rate of exposure among Tests frequency of disease ● exposed and those not among those exposed and exposed is studied those not exposed First approach to testing Reserved for testing ● hypothesis precisely define hypothesis
  • 19.  Involves small number of Involves large number of ● subjects subjects  Less time and resources More time and cost ● intensive  Suitable for rare diseases Difficult to conduct for ● rare diseases  Yields odds ratio Yields incidence rates, ● RR, AR and population atributable risk  Cannot yield information Information about more ● about diseases one other than disease is possible than selected for
  • 20. Randomized Control Studies  Essential elements are:  Drawing up a strict protocol,  selecting reference and  experimental populations,  randomization,  intervention,  follow-up  assessment of outcome.
  • 21.  Randomization is a statistical procedure where participants are allocated into groups called study and control groups to receive or not to receive an experimental therapeutic or preventive procedure, intervention. Randomization is an attempt to avoid bias and allow comparability.
  • 22.  Study designs include Concurrent parallel Crossover type of study designs.  In the former, study and control groups will be studied parallel whereas in the latter all the participants will have the benefit of treatment after a particular period because the control group becomes study group.
  • 23. Types of randomized control studies are: Clinical trials, e.g. drug trials Preventive trials, e.g. trials of vaccines Risk factor trials, e.g. trials of risk factors of cardiovascular disease, e.g. tobacco use, physical activity, diet, etc. Cessation experiments, e.g. smoking cessation experiments for studying lung cancer.
  • 24. What is bias?  Bias is systematic error that comes in.  Bias on the part of participants if they know they belong to study group—participant bias  bias because of observer if he knows that he is dealing with study group—observer bias  bias because of investigator investigator bias, if he knows he is dealing with study group. In order to prevent this, a technique called blinding is adopted.
  • 25. Concept of blinding  Single blind trial means participant will not know whether he belongs to study group or control group.  In double blind studies, both the participant and the observer will not be aware.  In triple blind study, the participant, observer as well as the investigator will not be aware